ACADIA Pharmaceuticals (ACAD) Financial Ratios: P/E, ROE & More

ACADIA Pharmaceuticals (ACAD) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), ACADIA Pharmaceuticals had a P/E ratio of 11.56 (down from 13.48), return on equity of 39.9% (up from 38.9%), debt-to-equity of 0.04 (down from 0.07) and a current ratio of 3.83 (up from 2.38). A current ratio of 3.83 means current assets exceed current liabilities.

ACADIA Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Valuation Ratios
P/E Ratio	11.56	13.48	-	-	-	-
Forward P/E	40.38	35.90	27.40	-	-	-
P/S Ratio	4.22	3.19	7.08	4.98	7.75	19.24
P/B Ratio	3.68	4.17	11.91	6.44	6.94	13.55
Price/Tangible Book	4.04	4.98	14.04	6.44	6.94	13.58
Price/FCF	42.98	19.42	308.70	-	-	-
Price/OCF	41.14	19.36	307.78	-	-	-
PEG Ratio	7.43	-	-	-	-	-
Enterprise Value Ratios
EV/Revenue	3.48	2.65	6.68	4.26	6.77	17.89
EV/EBITDA	31.97	25.33	-	-	-	-
EV/EBIT	35.56	30.11	-	-	-	-
EV/FCF	35.44	16.14	291.36	-	-	-
Profitability & Returns
Return on Equity (ROE)	39.89%	38.89%	-14.73%	-45.89%	-28.75%	-42.47%
Return on Assets (ROA)	4.76%	5.44%	-6.86%	-21.70%	-14.37%	-18.66%
Return on Invested Capital (ROIC)	42.90%	187.48%	-153.38%	-343.44%	-263.80%	-833.48%
Return on Capital Employed (ROCE)	8.10%	10.60%	-14.80%	-48.40%	-28.20%	-34.60%
Leverage & Solvency Ratios
Debt/Equity	0.04	0.07	0.13	0.15	0.12	0.08
Debt/EBITDA	0.40	0.47	-	-	-	-
Debt/FCF	0.50	0.33	3.44	-	-	-
Liquidity Ratios
Current Ratio	3.83	2.38	2.42	4.04	6.43	6.77
Quick Ratio	3.49	2.18	2.13	3.82	6.10	6.44
Efficiency Ratios
Asset Turnover	0.78	0.99	1.09	0.80	0.65	0.56
Inventory Turnover	14.76	13.33	18.53	51.22	29.44	35.81
Yield & Distribution Ratios
Earnings Yield	8.65%	7.42%	-1.19%	-8.38%	-4.47%	-3.31%
FCF Yield	2.33%	5.15%	0.32%	-4.42%	-3.38%	-1.69%
Buyback Yield	-2.14%	-1.55%	-1.32%	-0.74%	-2.01%	-6.88%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About ACADIA Pharmaceuticals Financial Ratios

What is ACADIA Pharmaceuticals's P/E ratio?

ACADIA Pharmaceuticals's P/E ratio was 11.56 for fiscal 2025 (period ended Dec 31, 2025). It was 13.48 a year earlier.

What is ACADIA Pharmaceuticals's return on equity?

ACADIA Pharmaceuticals's return on equity (ROE) was 39.9% for fiscal 2025 (period ended Dec 31, 2025). It was 38.9% a year earlier.

What is ACADIA Pharmaceuticals's debt-to-equity ratio?

ACADIA Pharmaceuticals's debt-to-equity ratio was 0.04 for fiscal 2025 (period ended Dec 31, 2025). It was 0.07 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition